Analysis of complement-bound HCV complexes using a novel immuno-capture RT-PCR method

Scandinavian Journal of Immunology

Volumn 56, Issue 5, 2002, Pages 538-542

  Zhu, H ^a   Wang, S Y ^a   Zhang, J Y ^a   Lian, Q Z ^a   Peng, X X ^a  

^a XIAMEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; VIRUS ANTIBODY; VIRUS RNA;

ADULT; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; IMMUNO CAPTURE REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; ANTIGEN-ANTIBODY COMPLEX; BASE SEQUENCE; COMPLEMENT C1Q; DNA, VIRAL; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SENSITIVITY AND SPECIFICITY;

EID: 0036434085     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.2002.01164.x     Document Type: Article

References (22)

1. Zhang JY, Dai M, Wang X et al. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma, in Hunan, China. Int J Epidemiol 1998;27:574-8.
2. Tsai JF, Jeng JE, Ho MS, Chang WY, Lin ZY, Tsai JH. Effect of hepatitis C and B virus infection on risk of hepatocellular carcinoma: A prospective study. Br J Cancer 1997;76:968-74.
3. Seeff LB. Natural history of hepatitis C. Am J Med 1999;107:10S-15S.
4. Tsai SL, Liaw YF, Chen MH, Huang CY, Kuo G. Detection of type 2-like T-helper cells in hepatitis C virus infection: Implications for hepatitis C virus chronicity. Hepatology 1997;25:449-58.
5. Kuzushita N, Hayashi N, Katayama K et al. High levels of serum interleukin-10 are associated with a poor response to interferon treatment in patients with chronic hepatitis C. Gastroenterology 1997;32:169-74.
6. Monsnier JF, Degott C, Marcellin P, Henin D, Erlinger S, Benhan JP. The intraportal lymphoid nodule and its environment chronic active hepatitis C: An immunohistochemical study. Hepatology 1993; 17:366-71.
7. Kobayashi M, Tanaka E, Matsumoto A, Ichijo T, Kiyosawa K. Antibody response to E2/NS1 hepatitis C virus protein in patients with acute hepatitis C. J Gastroenterol Hepatol 1997;12:73-6.
8. Almroth G, Ekermo B, Mansson AS, Svensson G, Widell A. Detection and prevention of hepatitis C in dialysis patients and renal transplant recipients. A long-term follow up (1989-January 1997). J Intern Med 2002;251:119-28.
9. Tsai JF, Jeng JE, Chang WY, Ho MSh, Lin ZY, Tsai JH. Circulating complexes in chronic hepatitis C. J Med Virol 1995;46:12-7.
10. Peng XX, Zhu H, Zhang JY, Wang SY. Analysis of HCV-Ig isotype complexes by a novel immuno-capture RT-PCR method. Scand J Immunol 2001;54:409-13.
11. Peng XX, Tao YZ, Wainberg MA, Brenner B. Immunoglobulin and complement complexes in blood following infection with human immunodeficiency virus type 1. Clin Diagn Lab Immunol 1996;3:128-32.
12. Pfeifer PH, Brems JJ, Brunson M, Hugli TE. Plasma C3a and C4a levels in liver transplant recipients: A longitudinal study. Immunopharmacology 2000;46:163-74.
13. Peng XX, Luo W, Zhang JY, Wang SY. Rapid detection of Shigella species in environmental sewage by an immuno-capture PCR with universal primers. Appl Environ Microbiol 2002;68:2580-3.
14. Peng XX, Zhang JY, Wang SY, Lin ZL, Zhang WY. Immunocapture PCR for detection of Aeromonas hydrophila. J Microbiol Methods 2002;49:335-8.
15. Peng XX, Wang SY, Zhang JY, Zhu H. Analysis of HCV-immunoglobulin isotype complexes provide new insights into antibody response to HCV. Scand J Immunol 2002;56:94-100.
16. Matsushita M, Fujita T. Activation of the classical complement pathway by mannose-binding protein in association with a novel Cls-like serine protease. J Exp Med 1992;176:1497-503.
17. Zimmermann-Nielsen E, Baatrup G, Thorlacius-Ussing O, Agnholt J, Svehag SE. Complement activation mediated by mannan-binding lectin in plasma from healthy individuals and from patients with SLE, Crohn's disease and colorectal cancer. Suppressed activation by SLE plasma. Scand J Immunol 2002;55:105-10.
18. Liu H, Jensen L, Hansen Set al. Characterization and quantification of mouse mannan-binding lectins (MBL-A and MBL-C) and study of acute phase responses. Scand J Immunol 2001;53:489-97.
19. Ogden CA, deCathehneau A, Hoffmann PR et al. Clq and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J Exp Med 2001;194:781-95.
20. Arora M, Munoz E, Tenner AJ. Identification of a site on mannan-binding lectin critical for enhancement of phagocytosis. J Biol Chem 2001;276:43087-94.
21. Petersen SV, Thiel S, Jensenius JC. The mannan-binding lectin pathway of complement activation: Biology and disease association. Mol Immunol 2001;38:133-49.
22. Lambris JD, Reid KBM, Volanakis JE. The evolution, structure, biology and pathophysiology of complement. Immunol Today 1999;20:207-11.